695 Results

People

  1. Zelenetz
    Zelenetz
  2. Moskowitz
    Moskowitz
  3. Portlock
    Portlock
  4. Giralt
    Giralt
  5. Straus
    Straus
  6. Horwitz
    Horwitz
  7. Tallman
    Tallman
  8. Jakubowski
    Jakubowski
  9. Perales
    Perales
  10. Noy
    Noy

Groups

  1. Center for Hematologic Malignancies (695)
  2. Department of Medicine (627)
  3. Hematologic Malignancies, Division of (595)
  4. Lymphoma (225)
  5. Survivorship Research (203)
  6. Adult Leukemia (192)
  7. Bone Marrow Transplant (163)
  8. GSK Faculty (156)
  9. Population Sciences Research Program (126)
  10. Epidemiology and Biostatistics (120)
Refine Results
  1. "aged"
  2. "Center for Hematologic Malignancies"
Formats
  1. Journal Article (679)
  2. Research Letter (11)
  3. Conference Paper (2)
  4. Correspondence (1)
  5. Meeting Abstract (1)
  6. Review (1)
Groups
  1. Center for Hematologic Malignancies (695)
  2. Department of Medicine (627)
  3. Hematologic Malignancies, Division of (595)
  4. Lymphoma (225)
  5. Survivorship Research (203)
  6. Adult Leukemia (192)

More Groups

People
  1. Andrew Zelenetz (83)
  2. Craig Moskowitz (59)
  3. Carol Portlock (56)
  4. David Straus (55)
  5. Sergio Giralt (55)
  6. Steven Horwitz (53)

More People

Years
  1. 2022 (18)
  2. 2021 (23)
  3. 2020 (69)
  4. 2019 (43)
  5. 2018 (34)
  6. 2017 (21)

More Years

Publications
  1. Blood (76)
  2. Journal of Clinical Oncology (68)
  3. Biology of Blood and Marrow Transplantation (43)
  4. Cancer (39)
  5. Leukemia and Lymphoma (30)
  6. British Journal of Haematology (27)

More Publications

Publishers
  1. American Society of Hematology (102)
  2. Elsevier Inc. (98)
  3. American Society of Clinical Oncology (72)
  4. Nature Publishing Group (57)
  5. Wiley Blackwell (50)
  6. John Wiley & Sons (39)

More Publishers

Results (695)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of conditioning regimen intensity on the outcomes of peripheral T-cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma patients undergoing allogeneic transplant
    Journal Article

    Savani, M.; Ahn, K. W.; Chen, Y.; Ahmed, S.; Cashen, A. F.; Shadman, M.; Modi, D.; Khimani, F.; Cutler, C. S.; Zain, J.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma
    Journal Article

    Lin, R. J.; Owens, C. N.; Drill, E.; Iannotta, A.; Oliveros, M.; Schick, D. L.; Noy, A.; Gerecitano, J. F.; Drullinsky, P. R.; Caron, P. C.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: A detailed analysis from the phase III ECHELON-1 study
    Journal Article

    Evens, A. M.; Connors, J. M.; Younes, A.; Ansell, S. M.; Kim, W. S.; Radford, J.; Feldman, T.; Tuscano, J.; Savage, K. J.; Oki, Y.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Characteristics and outcome of extranodal NK/T-cell lymphoma in North America: A retrospective multi-institutional experience
    Journal Article

    Bennani, N. N.; Tun, A. M.; Carson, K. R.; Geiger, J. L.; Maeda, L. S.; Savage, K. J.; Rose, J.; Pinter-Brown, L.; Lunning, M. A.; Abramson, J. S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • A phase I study of the fully human, fragment crystallizable-engineered, anti-CD-33 monoclonal antibody BI 836858 in patients with previously-treated acute myeloid leukemia
    Research Letter

    Vasu, S.; Altman, J. K.; Uy, G. L.; Tallman, M. S.; Gojo, I.; Lozanski, G.; Burkard, U.; Osswald, A.; James, P.; Rüter, B.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission
    Journal Article

    Shadman, M.; Pasquini, M.; Ahn, K. W.; Chen, Y.; Turtle, C. J.; Hematti, P.; Cohen, J. B.; Khimani, F.; Ganguly, S.; Merryman, R. W.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes
    Journal Article

    Zeidan, A. M.; DeAngelo, D. J.; Palmer, J.; Seet, C. S.; Tallman, M. S.; Wei, X.; Raymon, H.; Sriraman, P.; Kopytek, S.; Bewersdorf, J. P.; more...
    Annals of Hematology (2022)

    Fulltext@MSK | Save
  • Impact of TP53 genomic alterations in large B-cell lymphoma treated with CD19-chimeric antigen receptor T-cell therapy
    Journal Article

    Shouval, R.; Alarcon Tomas, A.; Fein, J. A.; Flynn, J. R.; Markovits, E.; Mayer, S.; Afuye, A. O.; Alperovich, A.; Anagnostou, T.; Besser, M. J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Randomized phase III BMT CTN trial of calcineurin inhibitor-free chronic graft-versus-host disease interventions in myeloablative hematopoietic cell transplantation for hematologic malignancies
    Journal Article

    Luznik, L.; Pasquini, M. C.; Logan, B.; Soiffer, R. J.; Wu, J.; Devine, S. M.; Geller, N.; Giralt, S.; Heslop, H. E.; Horowitz, M. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Single-agent mosunetuzumab shows durable complete responses in patients with relapsed or refractory b-cell lymphomas: Phase 1 dose-escalation study
    Journal Article

    Budde, L. E.; Assouline, S.; Sehn, L. H.; Schuster, S. J.; Yoon, S. S.; Yoon, D. H.; Matasar, M. J.; Bosch, F.; Kim, W. S.; Nastoupil, L. J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save